Victory! DC Council Passes Copay Limitation Act
On December 20, 2016, the DC Council approved the Specialty Drug Copayment Limitation Act, a bill that will stem the onerous and increasingly common health insurer practice of cost-shifting by limiting the out-of-pocket patient expense for certain specialty drugs to $150 for a 30-day supply, and $300 for a 90-day supply. The Council vote marks the final approval by the DC Council and comes after almost two full years of ongoing and vigorous advocacy by the Medical Society and a stakeholder coalition.
This year-end victory demonstrates the power of the physician voice in the District of Columbia and the strength of physicians who work together. MSDC thanks the physician members who helped secure passage of this legislation by testifying at hearings and responding to calls to action. Their work, together with the vigorous, ongoing advocacy by the Medical Society and the stakeholder coalition, kept this legislation - and the many patients whom it will help - on the DC Council's radar, helping to ensure its passage